Sep 23, 2025
Introducing an all-in-one probiotic solution combining Pre-, Pro-, and Postbiotics for comprehensive gut health
ILDONG BIOSCIENCE Co., Ltd., a health functional food subsidiary of ILDONG Pharmaceutical Group, announced its participation in Vitafoods Asia 2025, held from September 17 to 19 in Bangkok, Thailand, to explore new business opportunities and strengthen its presence in the Asian market.
Recognized as the largest nutraceutical and functional food exhibition in the Asia-Pacific region, Vitafoods Asia attracts global leaders in the health and nutrition industries. During the event, ILDONG Bioscience showcased its advanced probiotic technologies, including its proprietary quadruple coating process (Q-Shield® technology), and presented a broad portfolio of functional ingredients and finished products tailored for global OEM/ODM collaborations.
Among its latest innovations, the company gained strong interest with its “PPP Probiotics” — a next-generation formulation that integrates prebiotics, probiotics, and postbiotics in a single product.
Prebiotics support the growth and activity of beneficial gut bacteria.
Probiotics are live microorganisms that contribute to gut and immune health.
Postbiotics are bioactive compounds produced by probiotics that offer additional physiological benefits.
By combining all three elements, ILDONG’s PPP Probiotics deliver synergistic gut health effects, offering both functional efficacy and consumer convenience.
In addition to its exhibition activities, ILDONG Bioscience participated in a technical seminar hosted by the Korea Health Supplements Association, where it introduced its latest postbiotic research related to functional gastrointestinal disorders and discussed commercialization technologies supporting product development.
ILDONG Bioscience has been collaborating with a leading Thai healthcare distributor since 2022, supplying probiotic ingredients and semi-finished products. The company is now expanding its operations to include finished product supply and ODM partnerships, reinforcing its commitment to the regional market.
A company representative stated,
“Leveraging over 20 GRAS-certified probiotic and postbiotic ingredients approved by the U.S. FDA, ILDONG Bioscience will continue to develop market-specific formulations and broaden its global marketing strategies to enhance competitiveness worldwide.”